BCA
CVAC

Berman Capital Advisors’s CureVac CVAC Stock Holding History

Berman Capital Advisors’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$0 Buy
+18
New +$1.08K ﹤0.01% 2090

Other funds holding CVAC

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Berman Capital Advisors's CVAC Position: Q3 2021 in Review

Berman Capital Advisors opened a new position in CureVac (CVAC) in Q3 2021: 18 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #2090 among its holdings.

111 funds tracked by Wall St. Rank hold CVAC as of Q3 2021.

  • Berman Capital Advisors held 18 shares of CureVac worth $0 as of Q3 2021.
  • CureVac was a new Berman Capital Advisors position in Q3 2021.
  • CureVac made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #2090 holding.
  • 111 funds tracked by Wall St. Rank held CureVac as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.